With the year of the tiger approaching, the 400 billion pharmaceutical giant Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) (300760. SZ) launched its first employee stock ownership plan four years after its listing.
On January 19, Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) disclosed the draft employee stock ownership plan for 2022, which plans to sell more than 3 million shares to employees at the price of 50 yuan per share. The reporter of the daily economic news noted that the price was 1.5% off the current price.
push ESOP at a discounted price
motivate core employees and technical backbone
At the close on January 19, Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) share price was 335.22 yuan. In contrast, the purchase price of 50 yuan / share is actually giving “benefits” to employees.
In this regard, Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) also said that the purpose of implementing the ESOP is to establish and improve the benefit sharing mechanism of employees and shareholders, improve the level of corporate governance, improve the cohesion of employees and the competitiveness of the company, mobilize the enthusiasm and creativity of employees, and promote the long-term, sustainable and healthy development of the company.
The announcement shows that the ESOP covers Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) core employees and technical backbones, with a total number of no more than 2700 and a total capital of no more than 150 million yuan.
According to the disclosure, the shares of the employee stock ownership plan come from the common shares repurchased by Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) , with a total of no more than 3.05 million shares, accounting for about 0.25% of the current total share capital of 1.2 billion shares, all from the repurchase of Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) last August.
In August 2021, Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) threw out a repurchase plan worth 1 billion yuan and completed its implementation on September 1 of that year. The highest transaction price was 335 yuan / share and the lowest transaction price was 316.18 yuan / share.
It is worth noting that Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) has also set performance growth assessment indicators for this ESOP, that is, the annual net profit increases by 20%.
Meanwhile, the duration of the employee stock ownership plan is 48 months, which will be terminated automatically after the expiration of the duration, and employees can also extend it before the expiration.
benefit covid-19 detection
Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) significant performance growth
Such a generous hand is naturally inseparable from Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) solid family wealth.
In the first three quarters of 2021, Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) achieved a revenue of 19.392 billion yuan, a year-on-year increase of 20.72%, and the net profit attributable to the parent company was 6.663 billion yuan, a year-on-year increase of 24.23%.
Since 2017, Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) revenue and net profit have always maintained an increase of more than 20%.
From 2017 to 2020, Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) achieved revenue of 11.174 billion yuan, 13.753 billion yuan, 16.556 billion yuan and 21.026 billion yuan respectively, with a year-on-year increase of 23.72%, 23.09%, 20.38% and 27%; The net profit attributable to the parent company was 2.589 billion yuan, 3.719 billion yuan, 4.681 billion yuan and 6.658 billion yuan respectively, with a year-on-year increase of 61.81%, 43.65%, 25.85% and 42.24%.
In 2021, Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) topped the list of hot stocks in institutional research. According to the data of China stock market news choice, Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) the total number of institutional reception reached 3065 times in the whole year.
Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) is highly sought after and has a lot to do with its labels of “covid-19 testing concept stock” and “leading medical device enterprise”.
According to the annual report, Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) main products cover three fields: life information and support, in vitro diagnosis and medical imaging. It not only “has the most complete product line in China’s industry”, but also “China’s largest and world leading supplier of medical devices and solutions”.
With the global outbreak of covid-19 epidemic, in 2020, Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) added more than 700 high-end customers in the international market, exceeding the sum of the growth of high-end customers in the international market over the years. The company bluntly said, “the company’s brand promotion has been advanced by at least five years.”
On January 6 this year, Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) said on the investor interaction platform that in terms of covid-19 detection, the company has covid-19 antibody detection reagent. At present, it has obtained the registration certificate of CE and overseas countries, mainly for overseas sales.
extended reading
“Year end bonus” likes to mention BMW and Xiaopeng! The A-share company has sent 28 cars to its employees and 435 prize cars for 14 consecutive years!
Swipe the screen! Wahaha sends 600 million year-end bonus! In addition, the company pays 40 monthly salaries and some people get 50 million year-end bonuses
